Glaxo plans to introduce hepatitis-B, asthma drugs
Glaxo plans to introduce its patented drugs lamuvidine, the only drug for hepatitis-B, and Ventoride, the asthma drug, under the exclusive marketing rights (EMR) provision. The company is said to be
Glaxo plans to introduce its patented drugs lamuvidine, the only drug for hepatitis-B, and Ventoride, the asthma drug, under the exclusive marketing rights (EMR) provision. The company is said to be